other material
confidence high
sentiment neutral
materiality 0.35
Century Therapeutics updates ATM program; $131.6M remaining under $150M facility
Century Therapeutics, Inc.
- New prospectus supplement filed March 26, 2026 for existing ATM program under effective shelf.
- Up to $150M in common stock may be sold via ATM; $18.38M already sold.
- $131.62M remains available for future issuance through TD Securities as agent.
- Goodwin Procter LLP opinion on share validity included as Exhibit 5.1.